Article

Postoperative hyperprogression disease of pancreatic ductal adenocarcinoma after curative resection: A retrospective cohort study.

2022-02-17

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Prognosis for patients recurred rapidly after resection of pancreatic ductal adenocarcinoma (PDAC) was extremely poor. We proposed the concept of postoperative hyper-progression disease (PO-HPD) to define recurrence within 2 months after surgery, explored the role of surgery for postoperative HPD patients and determined the predictive preoperative risk factors a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9e672dc0-5293-53c0-966a-623d5727d749
DOI: 10.21203/rs.3.rs-1334546/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Postoperative hyperprogression disease of pancreatic ductal adenocarcinoma after curative resection: A retrospective cohort study.DOI 10.21203/rs.3.rs-1334546/v1Read

Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer RecurrenceSemantic proximity Read

Predicting disease recurrence in pancreatic ductal adenocarcinomaSemantic proximity Read

DAXX is associated with early recurrence of pancreatic neuroendocrine tumors after R0 resection.Semantic proximity Read

Tumor copy number instability is a significant predictor for late recurrence after radical surgery of pancreatic ductal adenocarcinoma.Semantic proximity Read

Molecular Alterations Associated with DNA Repair in Pancreatic Adenocarcinoma Are Associated with Sites of Recurrence.Semantic proximity Read

Unexpected Long-Term Survival in Resected Pancreatic Ductal Adenocarcinoma Harboring KRAS G12D/SMAD4 Co-Mutation: A Case Report and Mini-ReviewSemantic proximity Read

Ongoing Replication Stress Response and New Clonal T Cell Development Discriminate Between Liver and Lung Recurrence Sites and Patient Outcomes in Pancreatic Ductal AdenocarcinomaSemantic proximity Read

[Progress of circulating tumor DNA in diagnosis and prognosis of pancreatic cancer].Semantic proximity Read

The Evolutionary Origins of Recurrent Pancreatic CancerSemantic proximity Read

Evolutionary Origins of Recurrent Pancreatic CancerSemantic proximity Read

Loss of ATRX and DAXX in pancreatic neuroendocrine tumors: Association with recurrence risk, cellular phenotype, and heterogeneity.Semantic proximity Read

Peritoneal Cell-Free Tumor DNA is a Biomarker of Locoregional and Peritoneal Recurrence in Resected Pancreatic Ductal Adenocarcinomas.Semantic proximity Read